Vericel Corp. (VCEL)
42.36
-0.32
(-0.76%)
USD |
NASDAQ |
Aug 24, 16:00
42.36
0.00 (0.00%)
After-Hours: 19:56
Vericel Shareholders Equity (Quarterly) : 370.04M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 370.04M |
| March 31, 2026 | 356.23M |
| December 31, 2025 | 354.64M |
| September 30, 2025 | 321.86M |
| June 30, 2025 | 306.81M |
| March 31, 2025 | 295.49M |
| December 31, 2024 | 291.97M |
| September 30, 2024 | 257.47M |
| June 30, 2024 | 242.98M |
| March 31, 2024 | 233.90M |
| December 31, 2023 | 225.95M |
| September 30, 2023 | 204.38M |
| June 30, 2023 | 198.93M |
| March 31, 2023 | 193.98M |
| December 31, 2022 | 192.27M |
| September 30, 2022 | 177.84M |
| June 30, 2022 | 174.82M |
| March 31, 2022 | 172.48M |
| December 31, 2021 | 170.46M |
| September 30, 2021 | 156.78M |
| June 30, 2021 | 151.09M |
| March 31, 2021 | 140.21M |
| December 31, 2020 | 134.26M |
| September 30, 2020 | 114.63M |
| June 30, 2020 | 107.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 110.45M |
| December 31, 2019 | 111.09M |
| September 30, 2019 | 96.99M |
| June 30, 2019 | 88.54M |
| March 31, 2019 | 103.06M |
| December 31, 2018 | 102.23M |
| September 30, 2018 | 94.48M |
| June 30, 2018 | 90.60M |
| March 31, 2018 | 20.94M |
| December 31, 2017 | 22.54M |
| September 30, 2017 | 16.74M |
| June 30, 2017 | 13.97M |
| March 31, 2017 | 15.50M |
| December 31, 2016 | 24.71M |
| September 30, 2016 | 11.39M |
| June 30, 2016 | 17.11M |
| March 31, 2016 | 19.23M |
| December 31, 2015 | 22.13M |
| September 30, 2015 | 26.41M |
| June 30, 2015 | 30.24M |
| March 31, 2015 | 31.70M |
| December 31, 2014 | 35.64M |
| September 30, 2014 | 37.78M |
| June 30, 2014 | 2.785M |
| March 31, 2014 | 3.769M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.359B |
| AbbVie, Inc. | -5.935B |
| Marker Therapeutics, Inc. | 12.17M |
| TG Therapeutics, Inc. | 604.08M |
| ADMA Biologics, Inc. | 408.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 502.87M |
| Total Liabilities (Quarterly) | 132.82M |
| Debt to Equity Ratio | 0.2556 |
| Current Ratio | 5.039 |
| Net Debt Paydown Yield | 0.06% |